Mayne Pharma | MYX - Cost Of Sales

Stock Price
2.63
Daily Change
-0.07 -2.59%
Monthly
-17.81%
Yearly
-43.80%
Q1 Forecast
2.74

Mayne Pharma reported AUD43.74M in Cost of Sales for its fiscal semester ending in June of 2024.





Cost Of Sales Change Date
Ansell USD 254.1M 232.2M Jun/2024
Avita Medical AUD 3.47M 1.19M Jun/2025
Cochlear AUD 158.85M 131.25M Jun/2025
CSL USD 1.79B 2.15B Jun/2025
Healius AUD 218.7M 110.8M Jun/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Medical Developments International AUD 2.18M 3.09M Jun/2025
Nanosonics AUD 23.12M 2.97M Jun/2025
Polynovo AUD 4.77M 2.77M Jun/2024
Ramsay Health Care AUD 2.98B 742.1M Jun/2025
ResMed USD 536.28M 21.52M Dec/2025
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024